Alkermes plc (ALKS)
NASDAQ: ALKS · Real-Time Price · USD
31.71
+0.71 (2.29%)
At close: Jun 6, 2025, 4:00 PM
31.70
-0.01 (-0.03%)
After-hours: Jun 6, 2025, 6:21 PM EDT
Alkermes Revenue
Alkermes had revenue of $306.51M in the quarter ending March 31, 2025, a decrease of -12.52%. This brings the company's revenue in the last twelve months to $1.51B, down -12.31% year-over-year. In the year 2024, Alkermes had annual revenue of $1.56B, down -6.36%.
Revenue (ttm)
$1.51B
Revenue Growth
-12.31%
P/S Ratio
3.44
Revenue / Employee
$840,983
Employees
1,800
Market Cap
5.23B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.56B | -105.77M | -6.36% |
Dec 31, 2023 | 1.66B | 551.61M | 49.61% |
Dec 31, 2022 | 1.11B | -61.96M | -5.28% |
Dec 31, 2021 | 1.17B | 135.00M | 13.00% |
Dec 31, 2020 | 1.04B | -132.19M | -11.29% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
ALKS News
- 5 days ago - Alkermes to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference - PRNewsWire
- 5 days ago - Alkermes Highlights Data From Psychiatry Portfolio at Spring 2025 Scientific Conferences - PRNewsWire
- 5 weeks ago - Alkermes: Label Expansion Of LYBALVI With Ongoing Pediatric Trial Possible - Seeking Alpha
- 5 weeks ago - Alkermes plc (ALKS) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Alkermes plc Reports First Quarter 2025 Financial Results - PRNewsWire
- 5 weeks ago - New Survey Provides Insights into Diagnosis and Treatment Journey for People Living With Alcohol Use Disorder (AUD) - PRNewsWire
- 7 weeks ago - Alkermes to Report First Quarter Financial Results on May 1, 2025 - PRNewsWire
- 2 months ago - Alkermes to Participate in the 24th Annual Needham Virtual Healthcare Conference - PRNewsWire